NEW YORK, May 14 - AlphaGene is up for sale, an executive at the company told GenomeWeb today.

"We are in the process of selling the company," said Donald McCarren, president and CEO of the privately held functional genomics firm. "We don't have the resources to fully develop the value inside the company."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.